Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis.
Bolondi L, Piscaglia F, Gatta A, Salerno F, Bernardi M, Ascione A, Ferraù O, Sacerdoti D, Visentin S, Trevisani F, Mazzanti R, Donati G, Arena U, Gentilini P; DOC (Decrease Of Complications in cirrhosis) Study Group.
Bolondi L, et al. Among authors: visentin s.
Clin Gastroenterol Hepatol. 2006 Nov;4(11):1395-402. doi: 10.1016/j.cgh.2006.06.005. Epub 2006 Aug 22.
Clin Gastroenterol Hepatol. 2006.
PMID: 16931172
Clinical Trial.